These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 23656261)
1. Nanotechnology: a versatile aid in our fight against AIDS. Banerjee R Nanomedicine (Lond); 2013 May; 8(5):675-7. PubMed ID: 23656261 [No Abstract] [Full Text] [Related]
2. Novel liquid formulation developed to deliver nanomedicine treatment for HIV/AIDS. Nanomedicine (Lond); 2010 Jul; 5(5):684. PubMed ID: 20662639 [No Abstract] [Full Text] [Related]
3. Potential of polymeric nanoparticles in AIDS treatment and prevention. Khalil NM; Carraro E; Cótica LF; Mainardes RM Expert Opin Drug Deliv; 2011 Jan; 8(1):95-112. PubMed ID: 21143001 [TBL] [Abstract][Full Text] [Related]
5. Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders. Muthu MS; Singh S Nanomedicine (Lond); 2009 Jan; 4(1):105-18. PubMed ID: 19093899 [TBL] [Abstract][Full Text] [Related]
6. Nanotechnology and glaucoma: a review of the potential implications of glaucoma nanomedicine. Kim NJ; Harris A; Gerber A; Tobe LA; Amireskandari A; Huck A; Siesky B Br J Ophthalmol; 2014 Apr; 98(4):427-31. PubMed ID: 24246373 [TBL] [Abstract][Full Text] [Related]
7. Nanomedicine opportunities for cardiovascular disease with perfluorocarbon nanoparticles. Lanza GM; Winter PM; Caruthers SD; Hughes MS; Cyrus T; Marsh JN; Neubauer AM; Partlow KC; Wickline SA Nanomedicine (Lond); 2006 Oct; 1(3):321-9. PubMed ID: 17716162 [TBL] [Abstract][Full Text] [Related]
8. New strategies for structure-guided design of AIDS antivirals. Blundell TL Prog Biophys Mol Biol; 2005 Jun; 88(2):191-2. PubMed ID: 15572154 [No Abstract] [Full Text] [Related]
9. Role of nanotechnology in developing new therapies for diseases of the nervous system. Jain KK Nanomedicine (Lond); 2006 Jun; 1(1):9-12. PubMed ID: 17716203 [No Abstract] [Full Text] [Related]
11. Nanotechnology enables superior medical therapies. Foldvari M; Elsabahy M Curr Drug Deliv; 2011 May; 8(3):225-6. PubMed ID: 21291383 [No Abstract] [Full Text] [Related]
12. Evaluating Nanomedicines: Obstacles and Advancements. Swierczewska M; Crist RM; McNeil SE Methods Mol Biol; 2018; 1682():3-16. PubMed ID: 29039088 [TBL] [Abstract][Full Text] [Related]
13. Nanoparticles and the blood coagulation system. Part I: benefits of nanotechnology. Ilinskaya AN; Dobrovolskaia MA Nanomedicine (Lond); 2013 May; 8(5):773-84. PubMed ID: 23656264 [TBL] [Abstract][Full Text] [Related]
14. Unique benefits of nanotechnology to drug delivery and diagnostics. McNeil SE Methods Mol Biol; 2011; 697():3-8. PubMed ID: 21116949 [TBL] [Abstract][Full Text] [Related]
15. Impact of nanoscience and nanotechnology on controlled drug delivery. Youan BB Nanomedicine (Lond); 2008 Aug; 3(4):401-6. PubMed ID: 18694301 [No Abstract] [Full Text] [Related]
16. Nanotherapeutics: emerging competent technology in neuroAIDS and CNS drug delivery. Saxena SK; Tiwari S; Nair MP Nanomedicine (Lond); 2012 Jul; 7(7):941-4. PubMed ID: 22846087 [No Abstract] [Full Text] [Related]
17. Liposome-nanoparticle hybrids for multimodal diagnostic and therapeutic applications. Al-Jamal WT; Kostarelos K Nanomedicine (Lond); 2007 Feb; 2(1):85-98. PubMed ID: 17716195 [TBL] [Abstract][Full Text] [Related]